Lucy Lu M.D.

Board Member at Veru Inc.

Are you Lucy Lu M.D.? Claim your profile
 
  • IDENTIFY corporate executives in Lucy Lu M.D.'s network and community.
  • FOLLOW changes in Lucy Lu M.D.'s employment and money-in-motion.
  • CONNECT with Lucy Lu M.D. through your network of contacts.

Lucy Lu M.D.'s Executive Work History


Current
Board Member, Veru Inc.
Past
To view Lucy Lu M.D.'s complete executive work history,
Age
42
 
 

Lucy Lu M.D.'s Biography


Lucy Lu, M.D. has served as our Executive Vice President and Chief Financial Officer since February 22, 2012. Dr. Lu has served as Interim President and Chief Executive Officer of Avenue Therapeutics, Inc., a subsidiary of the Company, since it was formed in February 2015. From to November 2014 to August 2015, Dr. Lu served as President and Chief Executive Officer of Checkpoint Therapeutics, Inc. Dr. Lu has over 10 years of experience in the healthcare industry. From February 2007 through January 2012, Dr. Lu was a senior biotechnology equity analyst with Citi Investment Research. From 2004 until joining Citi, she was with First Albany Capita ...

(Read More)

Source: Fortress Biotech, Inc. on 01/27/2017

 

By accessing Equilar Atlas, you can view bios, network, salary and wealth events of industry-leading executives like Lucy Lu M.D.. More specifically, you'll be able to:

  • IDENTIFY corporate executives in Lucy Lu M.D.'s network and community.
  • FOLLOW changes in Lucy Lu M.D.'s employment and money-in-motion.
  • CONNECT with Lucy Lu M.D. through your network of conections.
 

Search for over 360,000 executive profiles.

/bio

Example: Lucy Lu M.D.

Lucy Lu M.D.'s Connections (30)


President, Chief Executive Officer and Chairman of the Board, Fortress Biotech, Inc.
Vice President, Finance, Principal Financial and Accounting Officer, Treasurer and Secretary, Inotek Pharmaceuticals Corporation
Executive Chairman and Interim Chief Executive Officer and President, TG Therapeutics, Inc.
Former Executive Vice President and Chief Operating Officer, Fortress Biotech, Inc.